Companiesandmarkets.com

Vena cava filters market driven by the increasing number of mergers and acquisitions

Press Release   •   Jul 25, 2013 11:28 BST

The vena cava filters market has been forecast to increase at a compound annual growth rate (CAGR) of 11.37% through to 2016, driven by the increase in sales of retrievable filters, and the increasing number of mergers and acquisitions.

The broad 'health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry.

The growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.

A vena cava filter (VC filter) is a type of vascular filter, a medical device that is implanted by interventional radiologists or vascular surgeons into the inferior vena cava to presumably prevent life-threatening pulmonary emboli (PEs). Their effectiveness and safety profile is not well established, and in general, they are only recommended in some high-risk scenarios.

The vena cava filters market is currently experiencing a significant increase in the number of patent grants and approvals, thus authorising the utilisation of vena cava filters by patients.

For instance, Atrium Medical announced the completion of patient enrollment for the iCARUS in 2010. Rex Medical L.P. also received FDA approval as well as the CE mark approval for the Option retrievable vena cava filter in 2009.

Further, Cook Medical introduced the next-generation NavAlign system for streamlined IVC filter delivery in 2010. In addition to this, Lifetech Scientific Corp. obtained the CE mark approval for its vena cava filters in 2009.

One of the key challenges is the risk related to patients' health after the implantation of vena cava filters. Post an IVC filter implant, there are chances of patients suffering from complications such as chest pain, pericardial tamponade, or right ventricle punctures.

Key players currently dominating the vena cava filters market include B. Braun Melsungen AG, Boston Scientific Corp., C.R. Bard Inc., Cook Medical Inc., and Cordis Corp.

For more information on the vena cava filters market, see the latest research: Medical Device Market Research

Follow us on Twitter @CandMResearch

Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.